Abstract
Background: Warm‐up phenomenon, one of the clinical models of ischemic preconditioning, refers to an increased tolerance to myocardial ischemia during the second of two consecutive exercise tests.
Hypothesis: Blockers of K ATP channels, such as the sulfonylurea drugs, can induce loss of ischemic preconditioning. This study aimed to investigate the effects of glibenclamide, a sulfonylurea with a high affinity for myocardial K ATP channels, on the results of two consecutive exercise tests in diabetic patients with coronary artery disease.
Methods: Eighteen type II diabetic patients with chronic stable angina pectoris participated in this study. All patients underwent two consecutive treadmill exercise tests with a recovery period of 15 min in fasting state. On the day after these exercise tests, 10 mg oral glibenclamide was given to the same patients and 30 min later 200 ml of 30% glucose solution was given orally. Half an hour later, which is the time of peak plasma levels of glibenclamide, two exercise tests were repeated consecutively with a 15 min recovery period.
Results: There was no difference in blood glucose levels before and after exercise tests on each day (p > 0.05). Without glibenclamide, heart rate, rate‐pressure product at 1.5 mm ST depression, and peak exercise increased significantly (p < 0.05). Time to 1.5 mm ST‐segment depression and onset of pain, as well as duration of exercise also increased, but ST‐segment depression and ST‐recovery time significantly decreased (p < 0.05). In contrast, these values did not significantly change after glibenclamide (p > 0.05), with a significant drug—test interaction (p < 0.05, at two‐way ANOVA).
Conclusions: Glibenclamide, an oral hypoglycemic agent with a KATP channel‐blocker activity, with a 10 mg oral dose, abolished the warm‐up phenomenon which is a clinical finding of ischemic preconditioning on two consecutive exercise tests. Therefore, glibenclamide should be used carefully in patients with coronary heart disease and diabetes mellitus since this agent leads to a decrease in ischemic threshold and exercise capacity.
Keywords: glibenclamide, exercise test, ischemic preconditioning
Full Text
The Full Text of this article is available as a PDF (510.1 KB).
References
- 1. Okazaki Y, Kodama K, Sato H, Kitakaze M, Hirayama A, Mishima M, Hori M, Inoue M: Attenuation of increased regional myocardial oxygen consumption during exercise as a major cause of warm‐up phenomenon. J Am Coll Cardiol 1993; 21: 1597–1604 [DOI] [PubMed] [Google Scholar]
- 2. Maybaum S, Ilan M, Mogilevsky J, Tzivoni D: Improvement in ischemic parameters during repeated exercise testing: The possible model for myocardial preconditioning. Am J Cardiol 1997; 78: 1087–1091 [DOI] [PubMed] [Google Scholar]
- 3. Tomai F, Crea F, Danesi A, Perino M, Gaspardone A, Ghini AS, Cascarano MT, Chiariello L, Gioffre PA: Mechanisms of the warm‐up phenomenon. Eur Heart J 1996; 17: 1022–1027 [DOI] [PubMed] [Google Scholar]
- 4. Marber MS, Joy MD, Yellon DM: Is warm‐up in angina ischemic preconditioning? Br Heart J 1994; 72: 213–215 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Heberden W: A letter to Dr. Heberden concerning the angina pectoris: An account of the dissection of one who had been troubled with that disorder. Read at the college Nov 17, 1772. Med Trans Publ Coll Physicians Land 1785: 3: 1–11 [Google Scholar]
- 6. Grover GJ, Sleph PG, Dzwonczyk S: Role of myocardial ATP‐sensitive potassium channels in mediating preconditioning in the dog heart and their possible interaction with adenosine Al receptors. Circulation 1992; 86: 1310–1316 [DOI] [PubMed] [Google Scholar]
- 7. Gross GJ, Auehampach JA: Blockade of ATP‐sensitive potassium channels prevents myocardial preconditioning in dogs. Circ Res 1992; 70: 223–233 [DOI] [PubMed] [Google Scholar]
- 8. Tan HL, Mazon P, Verberne HJ, Sleeswijk ME, Coronel R, Opthof T, Janse MJ: Ischemic preconditioning delays ischemia induced cellular electrical uncoupling in rabbit myocardium by activation of ATP sensitive potassium channels. Carctiovasc Res 1993; 27: 644–651 [DOI] [PubMed] [Google Scholar]
- 9. Noma A: ATP‐regulated K channels in cardiac muscle. Nature 1983; 305: 147–148 [DOI] [PubMed] [Google Scholar]
- 10. Engler RL, Yellon DM: Sulfonylurea KATP blockade in type II diabetes and preconditioning in cardiovascular disease: Time for reconsideration. Circulation 1996: 94: 2297–2301 [DOI] [PubMed] [Google Scholar]
- 11. Klimt CR, Knatterud GL, Meinert CL, Prout TE (University Group Diabetes Program) : A study of the effects of hypoglycemic agents on vascular complications in patients with adult onset diabetes. Diabetes 1970; 19: 747–830 [PubMed] [Google Scholar]
- 12. The BARI (Bypass Angioplasty Revascularization Investigation) Investigators: Influence of diabetes on 5 year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. The Bypass Angioplasty Revascularization Investigation (BARI). Circulation 1997; 96: 1761–1769 [DOI] [PubMed] [Google Scholar]
- 13. Rytter L, Troelsen S, Beck‐Nielsen H: Prevalence and mortality of acute myocardial infarction in patients with diabetes. Diabetes Care 1985; 8: 230–234 [DOI] [PubMed] [Google Scholar]
- 14. Rentrop KP, Cohen M, Blanke H, Phillips R: Changes in collateral filling immediately following controlled coronary artery occlusion by an angioplasty balloon in man. J Am Coll Cardiol 1985; 5: 587–592 [DOI] [PubMed] [Google Scholar]
- 15. Karttunen P, Uusitupa M, Nykanen S, Robinson JD, Sipila J: The pharmocokinetics of glibenclamide: A single dose comparison of four preparations in human volunteers. Int J Clin Pharmacol 1985; 23: 642–646 [PubMed] [Google Scholar]
- 16. Tomai F, Crea F, Gaspardone A, Versaci F, De Paulis R, Penta de Peppo A, Chiariello L, Gioffre PA: Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide. a selective ATP sensitive K channel blocker. Circulation 1994; 90: 700–705 [DOI] [PubMed] [Google Scholar]
- 17. Tomai F, Danesi A, Ghini AS, Crea F, Perino M, Gaspardone A, Ruggeri G, Chiariello L, Gioffre PA: Effects of KATP channel blockade by glibenclamide on the warm‐up phenomenon. Eur Heart J 1999; 20: 196–202 [DOI] [PubMed] [Google Scholar]
- 18. Williams DO, Bass TA, Gewirtz H, Most A: Adaptation to stress of tachycardia in patients with coronary artery disease: Insight into the mechanisms of the warm‐up phenomenon. Circulation 1985; 71: 687–692 [DOI] [PubMed] [Google Scholar]
- 19. Yellon DM, Baxter GF, Garcia‐Dorado D, Heusch G, Sumeray MS: Ischaemic preconditioning: Present position and future directions. Cardiovasc Res 1998; 37: 21–33 [DOI] [PubMed] [Google Scholar]
- 20. Dana A, Yellon DM: ATP dependent K channel: A novel therapeutic target in unstable angina. Eur Heart J 1999; 20: 2–5 [PubMed] [Google Scholar]
- 21. Patel DJ, Purcell HJ, Fox KM: Cardioprotection by opening of the KATP channel in unstable angina. Is this a clinical manifestation of myocardial preconditioning? Results of a randomized study with nicorandil. Eur Heart J 1999; 20: 51–57 [DOI] [PubMed] [Google Scholar]
- 22. Speechly‐Dick ME, Graver GJ, Yellon DM: Does ischemic preconditioning in the human involve protein kinase C and ATP dependent K channel? Studies of contractile function after simulated ischemia in an atrial in vitro model. Circ Res 1995; 77: 1030–1035 [DOI] [PubMed] [Google Scholar]
- 23. Cleveland JC, Meldrum DR. Cain BS, Banerjee A, Harken AH: Oral sulfonylurea hypoglycemic agents prevent ischemic preconditioning in human myocardium. Two paradoxes revisited. Circulation 1997; 97: 29–32 [DOI] [PubMed] [Google Scholar]
- 24. Garratt KN, Brady PA, Hassinger NL, Grill DE, Terzic A, Holmes DR Jr: Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction. J Am Coll Cardiol 1999; 33: 119–124 [DOI] [PubMed] [Google Scholar]
- 25. Klepzig H, Kober G, Matter C, Luus H, Schneider H, Boedeker KH, Kiowski W, Amann FW, Gruber D, Harris S, Burger W: Sulfonylureas and ischaemic preconditioning. A double‐blind, placebo‐controlled evaluation of glimepiride and glibenclamide. Eur Heart J 1999; 20: 439–446 [DOI] [PubMed] [Google Scholar]